Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical Trial
Karen A. Autio, Robert Dreicer, Justine Anderson, Jorge A. Garcia, Ajjai Alva, Lowell L. Hart, Matthew I. Milowsky, Edwin M. Posadas, Charles J. Ryan, Ryon P. Graf, Ryan Dittamore, Nicole A. Schreiber, Jason M. Summa, Hagop Youssoufian, Michael J. Morris, Howard I. Scher
Dive into the research topics of 'Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical Trial'. Together they form a unique fingerprint.